Metabolic effect of docosahexaenoic acid supplementation in different doses and formulations (ethyl- and glyceryl-) in hypercholesterolemic rats

Journal of Functional Foods

Volumn 5, Issue 2, 2013, Pages 755-762

  Tabernero, Maria ^a   Bermejo, Laura M ^a   Elvira, Marcos ^a   Caz, Victor ^a   Baeza, Francisco ^b   Señorans, Francisco J ^c   De Miguel, Enrique ^a   Largo, Carlota ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b Nutra Omega Biotecnológica Oleica S L NOBO   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Bioactive ingredients; Docosahexaenoic acid; Long chain polyunsaturated omega 3 fatty acids; Metabolism; Obesity; Plasma lipid profile

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 84876716599     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.01.021     Document Type: Article

References (36)

1. Barrow C.J., Nolan C., Holub B.J. Bioequivalence of encapsulated and microencansulated fish-oil supplementation. Journal of Functional Foods 2009, 1:38-43.
2. Bernstein A.M., Ding E.L., Willett W.C., Rimm E.B. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. Journal of Nutrition 2012, 142:99-104.
3. Björntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997, 13:795-803.
4. Buckley J.D., Howe P.R. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obesity Reviews 2009, 10:648-659.
5. De Schrijver R., Vermeulen D., Backx S. Digestion and absorption of free and esterified fish oil fatty acids in rats. Lipids 1991, 26:400-404.
6. DeFina L.F., Marcoux L.G., Devers S.M., Cleaver J.P., Willis B.L. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. American Journal of Clinical Nutrition 2010, 93:455-462.
7. Djoussé L., Akinkuolie A.O., Wu J.H., Ding E.L., Gaziano J.M. Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis. Clinical Nutrition 2012, 31:846-853.
8. Dyerberg J., Madsen P., Møller J.M., Aardestrup I., Schmidt E.B. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukotrienes and Essential Fatty Acids 2010, 83:137-141.
9. Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and " immunomodulating agent" (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010, 8:1796-1828. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA).
10. el Boustani S., Colette C., Monnier L., Descomps B., Crastes de Paulet A., Mendy F. Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 1987, 22:711-714.
11. Eslick G.D., Howe P.R., Smith C., Priest R., Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: A systematic review and meta-analysis. International Journal of Cardiology 2009, 24:4-16.
12. Flachs P., Horakova O., Brauner P., Rossmeisl M., Pecina P., Franssen-van Hal N., et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 2005, 48:2365-2375.
13. Flachs P., Mohamed-Ali V., Horakova O., Rossmeisl M., Hosseinzadeh-Attar M.J., Hensler M., et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006, 49:394-397.
14. Freinkel N., Singer D.L., Arky R.A., Bleicher S.J., Anderson J.B., Silbert C.K. Alcohol hypoglycemia. I. Carbohydrate metabolism of patients with clinical alcohol hypoglycemia and the experimental reproduction of the syndrome with pure ethanol. Journal of Clinical Investigation 1963, 42:1112-1133.
15. Health Council of the Netherlands (2006). Guidelines for a healthy diet 2006. Publication no. 2006/21E. ISBN: 978-90-5549-656-3.
16. Khandelwala S., Shidhayec R., Demontyd I., Lakshmye R., Guptae R., Prabhakarana D., et al. Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults. Journal of Functional Foods 2013, 5:36-43.
17. Kralovec J.A., Ewart H.S., Wright J.H.D., Watson L.V., Dennis D., Barrow C.J. Production and bioavailability of calcium and magnesium salts of omega-3 fatty acids. Journal of Functional Foods 2009, 1:217-221.
18. Krebs H.A., Freedland R.A., Hems R., Stubbs M. Inhibition of hepatic gluconeogenesis by ethanol. Biochemistry Journal 1969, 112:117-124.
19. Kris-Etherton P.M., Harris W.S., Appel L.J. Omega-3 fatty acids and cardiovascular disease: New recommendations from the American Heart Association. Arteriosclerosis Thrombosis and Vascular Biology 2003, 23:151-152.
20. Lecumberri E., Goya L., Mateos R., Alía M., Ramos S., Izquierdo-Pulido M., Bravo L. A diet rich in dietary fiber from cocoa improves lipid profile and reduces malondialdehyde in hypercholesterolemic rats. Nutrition 2007, 23:332-341.
21. Marik P.E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clinical Cardiology 2009, 32:365-372.
22. Mori T., Kondo H., Hase T., Tokimitsu I., Murase T. Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. Journal of Nutrition 2007, 137:2629-2634.
23. Mozaffarian D., Bryson C.L., Lemaitre R.N., Burke G.L., Siscovick D.S. Fish intake and risk of incident heart failure. Journal of American Colleage of Cardiology 2005, 45:2015-2021.
24. Neubronner J., Schuchardt J.P., Kressel G., Merkel M., von Schacky C., Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. European Journal of Clinical Nutrition 2011, 65:247-254.
25. Oliveira de Souza M.L., Masur J. Blood glucose and body temperature alterations induced by ethanol in rats submitted to different levels of food deprivation. Pharmacology Biochemistry and Behavior 1981, 15:551-554.
26. Power G.W., Newsholme E.A. Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle. Journal of Nutrition 1997, 127:2142-2150.
27. Reglero G., Frial P., Cifuentes A., García-Risco M.R., Jaime L., Marin F.R., et al. Meat-based functional foods for dietary equilibrium omega-6/omega-3. Molecular Nutrition and Food Research 2008, 52:1153-1161.
28. Rizos E.C., Nitzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. A systematic review and meta-analysis. Journal of the American Medical Association 2012, 308:1024-1033.
29. Scientific Advisory Committee on Nutrition (SACN), Advice on fish consumption: Benefits & risks (2004).
30. Schuchardt J.P., Neubronner J., Kressel G., Merkel M., von Schacky C., Hahn A. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial. Prostaglandins Leukotrienes and Essential Fatty Acids 2011, 85:381-386.
31. Schuchardt J.P., Schneider I., Meyer H., Neubronner J., von Schacky C., Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil. Lipids in Health and Disease 2011, 10:145-152.
32. Sumida K.D., Hill J.M., Matveyenko A.V. Sex differences in hepatic gluconeogenic capacity after chronic alcohol consumption. Clinical Medicine Research 2007, 5:193-202.
33. Thorsdottir I., Tomasson H., Gunnarsdottir I., Gisladottir E., Kiely M., Parra M.D., Bandarra N.M., Schaafsma G., Martinéz J.A. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. International Journal of Obesity 2007, 31:1560-1566.
34. Tsuzuki T., Kawakami Y., Nakagawa K., Miyazawa T. Conjugated docosahexaenoic acid inhibits lipid accumulation in rats. Journal of Nutritional Biochemistry 2006, 17:518-524.
35. Ulven S.M., Kirkhus B., Lamglait A., Basu S., Elind E., Haider T., et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46:37-46.
36. Wei M.Y., Jacobson T.A. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: A systematic review and meta-analysis. Current Atherosclerosis Reports 2011, 13:474-483.